FB 1 inhibits the enzyme ceramide synthase preventing the formation of ceramide. This disrupts the synthesis of critical sphingolipids downstream of ceramide, e.g. Sphingomyelin and glycosphingolipids. In the process precursors of ceramide increase in concentration, e.g. sphinganine, sphingosine1-phosphate as as deoxysphinganine and other deoxyspingoid bases (Riley et al, 2001; He t al, 2006 Zitomer et al, 2009). The accumulated metabolites are highly toxic causing cytotoxicity and cell death (apoptosis) (Yoo et al, 1996; Desai et al, 2002). In addition reactive oxygen species (ROS) have
been shown to be active in apoptosis and damage to DNA (Stockman-Juvala et al, 2004; Domijan et al, 2007).
Finally, the disruption of sphingolipid metabolism has been associated with neural tube defects (NTBs) in animal models in vivo and intro as well was in humans living along the Texas-Mexico border. The NTBs are discussed in the section on neurotoxicity and mycotoxins mentioned above (Marasas et al, 2003; Gelineau-van Waes et al, 2005, 2009; Missmer et al, 2006). In addition, intracerebroventricular administration of FB 1to mice caused neurodegeneration, disruption of sphingolipid metabolism, stimulation of astrocytes and release of pro-inflammatory cytokines: TNF-α, IL1 beta, IL6 and IF- gamma (Osuchowski et al, 2005)